Home
Drugs
Cetuximab
Clinical Trials

Clinical Trials Related to Cetuximab

Related studies linked through entity extraction aliases.

A Study to Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment

Status: UNKNOWN
Phase: PHASE1/PHASE2

Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer

Status: TERMINATED
Phase: PHASE2

c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRI

Status: UNKNOWN
Phase: PHASE2

FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases

Status: RECRUITING
Phase: PHASE2

PF-07284892 in Participants With Advanced Solid Tumors

Status: TERMINATED
Phase: PHASE1

Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer

Status: COMPLETED
Phase: PHASE1/PHASE2

Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB

Status: RECRUITING
Phase: PHASE3

A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

Status: RECRUITING
Phase: PHASE1

Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors

Status: TERMINATED
Phase: PHASE1/PHASE2

BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment

Status: RECRUITING
Phase: N/A

Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.

Status: COMPLETED
Phase: N/A

A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC

Status: WITHDRAWN
Phase: PHASE2

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

Status: COMPLETED
Phase: PHASE1/PHASE2

LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer

Status: COMPLETED
Phase: PHASE2